Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

503 public trials 139 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Completed

Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

NCT01471210

Conditions
Cancer - Solid Tumors and B-Cell Non-Hodgkin's Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Division Of Hematology & Oncology Ctr. For Health Sciences Los Angeles, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • University Of Chicago Chicago, Illinois, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
View all 24 locations
View Trial Details
Completed

Safety and Efficacy Study of a BTK Inhibitor in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma

NCT01325701

Conditions
Diffuse Large Cell B-lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Stanford University School of Medicine Stanford, California, United States
  • National Cancer Institute Bethesda, Maryland, United States
  • Mayo Clinic Rochester, Minnesota, United States
View all 15 locations
View Trial Details
Completed

A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma

NCT01421667

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • PMK Medical Group Inc., DBA Ventura County Hematology Oncology Specialists Oxnard, California, United States
  • Stanford Cancer Center Stanford, California, United States
View all 34 locations
View Trial Details
Completed

Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203)

NCT00147121

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Aichi Medical University Aichi-gun,Nagakute,Yazako,Karimata,21, Aichi-ken, Japan
  • Aichi Cancer Center Hospital Nagoya,Chikusa-ku,Kanokoden,1-1, Aichi-ken, Japan
  • Nagoya City University Hospital Nagoya,Mizuho-ku,Mizuho-cho,Kawasumi,1, Aichi-ken, Japan
  • Nagoya University School of Medicine Nagoya,Showa-ku, Tsurumai-cho,65, Aichi-ken, Japan
View all 45 locations
View Trial Details

Related conditions